ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Metalloproteinase"

  • Abstract Number: 0069 • ACR Convergence 2024

    Activation of Cardiovascular Inflammation and Wnt Signaling in Spondyloarthritis: Insights from the HLA-B27 Transgenic Rat Model

    Su-Ah Yoon, Chorong Kim, Hansun Song, Mie Jin Lim and Seong-Ryul Kwon, College of Medicine, Inha University, Incheon, Republic of Korea

    Background/Purpose: Despite the well-documented link between cardiovascular (CV) disease and spondyloarthritis (SpA), no animal studies have empirically validated this connection or integrated SpA, vascular inflammation,…
  • Abstract Number: 0459 • ACR Convergence 2024

    Tocilizumab Demonstrates Superior Inhibition of MMP-Mediated Basement Membrane Collagen Degradation Compared to Methotrexate or Placebo

    Dovile Sinkeviciute1, Sofie Falkenloeve Madsen2, Nicolas Willumsen3, Patryk Drobinski3, Morten Karsdal3 and Anne-Christine Bay-Jensen3, 1Nordic Bioscience, Herlev, Hovedstaden, Denmark, 2University of Copenhagen, Copenhagen N, Denmark, 3Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) pathogenesis involves a range of immune cells, for instance T-cells, neutrophils and macrophages. They produce proinflammatory factors, such as proteolytic enzymes,…
  • Abstract Number: 0470 • ACR Convergence 2024

    New Approach for Early and Accurate Diagnosis of Rheumatoid Arthritis-related Interstitial Lung Disease: Matrix Metalloproteinases 7 and 9 as Novel Blood Biomarkers

    Veronica Pulito-Cueto1, Belén Atienza-Mateo2, gonzalo Ocejo-Viñals3, Victor M. Mora-Cuesta4, David Iturbe-Fernández4, Joao Carlos Batista-Liz1, María Sebastián Mora-Gil5, Mónica Renuncio-García6, Elena González López3, José M. Cifrián7, Ricardo Blanco-Alonso8 and Raquel Lopez-mejias1, 1IDIVAL, Santander, Spain, 2Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 3Department of Immunology, Marqués de Valdecilla University Hospital (HUMV), Santander, Spain, 4Immunopathology Group, Valdecilla Research Institute (IDIVAL) and Department of Pneumology, Marqués de Valdecilla University Hospital (HUMV), Santander, 5Immunopathology Group, Valdecilla Research Institute (IDIVAL) and Department of Rheumatology, Marqués de Valdecilla University Hospital (HUMV), Santander, 6Division of Immunology, Hospital Universitario Marqués de Valdecilla, Immunopathology Group, IDIVAL, Santander, Spain, 7Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. Immunopathology group, IDIVAL, Santander, 8Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Interstitial lung disease (ILD) is one of the main causes of death in rheumatoid arthritis (RA) patients [1]. Early diagnosis of RA-ILD+ is critical…
  • Abstract Number: 0770 • ACR Convergence 2023

    Plasma Matrix Metalloproteinases in Rheumatoid Arthritis-Interstitial Lung Disease: Associations with Disease Presence, Severity, and Subtypes

    Brent Luedders1, Austin Wheeler1, Dana Ascherman2, Joshua Baker3, Michael Duryee1, Yangyuna Yang1, Punyasha Roul1, K Wysham4, Paul Monach5, Andreas Reimold6, Gail Kerr7, Gary Kunkel8, Grant Cannon9, Jill Poole1, Geoffrey Thiele1, Ted R Mikuls10 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pennsylvania, Philadelphia, PA, 4VA Puget Sound/University of Washington, Seattle, WA, 5VA Boston Healthcare System, Boston, MA, 6University of Texas Southwestern Medical Center, Dallas, TX, 7Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 8University of Utah, Salt Lake City, UT, 9University of Utah and Salt Lake City VA, Salt Lake City, UT, 10Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling that have been implicated in the pathogenesis and progression of rheumatoid arthritis (RA) and…
  • Abstract Number: 0771 • ACR Convergence 2023

    A Modified Idiopathic Pulmonary Fibrosis-Derived Composite Biomarker Score Is Associated with Interstitial Lung Disease Among U.S. Veterans with Rheumatoid Arthritis

    Brent Luedders1, Dana Ascherman2, Daniel Kass3, Joshua Baker4, Michael Duryee1, Yangyuna Yang1, Punyasha Roul1, K Wysham5, Paul Monach6, Andreas Reimold7, Gail Kerr8, Gary Kunkel9, Grant Cannon10, Jill Poole1, Geoffrey Thiele1, Ted R Mikuls11 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh School of Medicine, Pittsburgh, PA, 4University of Pennsylvania, Philadelphia, PA, 5VA Puget Sound/University of Washington, Seattle, WA, 6VA Boston Healthcare System, Boston, MA, 7University of Texas Southwestern Medical Center, Dallas, TX, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 9University of Utah, Salt Lake City, UT, 10University of Utah and Salt Lake City VA, Salt Lake City, UT, 11Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Based on the overlap in peripheral blood biomarkers associated with rheumatoid arthritis interstitial lung disease (RA-ILD) and idiopathic pulmonary fibrosis (IPF), a composite biomarker…
  • Abstract Number: 0020 • ACR Convergence 2022

    Redoxosomes Mediate a Feed-forward Loop of Cartilage Matrix Destruction Through α5β1 Integrin Signaling in Response to a Fibronectin Matrikine

    Michael Miao1, Peter Su2, Yang Cui1, John Collins3, Edward Bahnson1, Susan Chubinskaya4 and Richard Loeser1, 1University of North Carolina, Chapel Hill, NC, 2University of Technology, Ultimo, Australia, 3Thomas Jefferson University, Philadelphia, PA, 4Rush University, Chicago, IL

    Background/Purpose: Degradation of pericellular matrix proteins creates bioactive fragments called "matrikines" that include fibronectin fragments (FN-f). FN-f found in OA cartilage and synovial fluid exhibit…
  • Abstract Number: 0026 • ACR Convergence 2022

    Silencing of WISP-2 Induces Inflammatory Mediators and Catabolic Factors in Cartilage

    Clara Ruiz-Fernández1, María González-Rodríguez2, Vera Francisco3, Djedjiga Ait Eldjoudi2, Alfonso Cordero-Barreal2, Yousof Farrag2, Jesús Pino4, Miguel Ángel González-Gay5, Antonio Mera6, Francisca Lago2 and Oreste Gualillo7, 1Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Galicia, Spain, 2Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain, 3Institute of Health Research-INCLIVA, València, Spain, 4Santiago Clinic Hospital CHUS-Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain, 5Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 6Santiago University Clinical Hospital CHUS, Santiago de Compostela, Spain, 7Hospital Clínico Universitario de Santiago, SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago de Compostela, Spain

    Background/Purpose: Wnt-1 inducible signaling pathway protein 2 (WISP-2/CCN5) is an adipokine that has been described as an important mediator of canonical Wnt activation in adipogenic…
  • Abstract Number: 2044 • ACR Convergence 2022

    Abnormalities of Extracellular Matrix Modeling Gene Expression in Salivary Gland Epithelial Cells of Patients with Sjögren’s Syndrome

    Elodie Riviere1, Juliette Pascaud1, Franck Letourneur2, Gaetane Nocturne3 and Xavier Mariette4, 1Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, France, 2Genomic, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 3APHP, Le Kremlin Bicêtre, France, 4Paris-Saclay University, Rueil Malmaison, Ile-de-France, France

    Background/Purpose: Salivary gland epithelial cells (SGECs) are not only the target of autoimmunity in primary Sjögren's syndrome (pSS). SGECs may interact with lymphocytes and therefore…
  • Abstract Number: 2262 • ACR Convergence 2022

    Albumin-hitchhiking MMP13 siRNA Conjugate (siMMP13< (EG18L)2) for the Treatment of Rheumatic Disease

    Juan Colazo1, Ella Hoogenboezem1, Fang Yu1, Veeraj Shah1, Justin Lo1, Hongsik Cho2, Karen Hasty2, Leslie Crofford3 and Craig Duvall1, 1Department of Biomedical Engineering, Vanderbilt University, Nashville, Nashville, TN, 2Department of Orthopaedic Surgery and Biomedical Engineering, Memphis VA Medical Center, Memphis, TN, 3Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Osteoarthritis (OA) and rheumatoid arthritis (RA) decrease quality of life due to joint destruction, pain, and decreased function. Multiple joint osteoarthritis (MJOA) can occur…
  • Abstract Number: 0026 • ACR Convergence 2021

    Synovial Fibroblasts Acquire a Proinflammatory and Destructive Phenotype After Exposure to αS1-Casein (CSN1S1)

    Nadine Honke1, Tim Appel1, Matthias Schneider2 and Georg Pongratz3, 1Department of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany (* contributed equally), Düsseldorf, Germany, 2Policlinic & Hiller Research Unit Rheumatology, UKD, Heinrich-Heine University, Düsseldorf, Germany, 3Polyclinic and Functional Area for Rheumatology & Hiller Research Center Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany

    Background/Purpose: The milk protein αS1-Casein (CSN1S1) was described to be overexpressed in synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Recently we…
  • Abstract Number: 1455 • ACR Convergence 2021

    IL1β mRNA Expressions in Peripheral Blood Mononuclear Cells Increase and May Associate with Cartilage Damage of the Respiratory Tract Probably Through Matrix metalloproteinase-3 Production in Patients with Relapsing Polychondritis

    Jun Shimizu1, Sueshige Wakisaka1, Tomoko Suzuki1 and Noboru Suzuki2, 1St. Marianna University School of Medicine, Kawasaki, Japan, 2St. Marianna University School of Medicine, Kawasaki Kanagawa, Japan

    Background/Purpose: Relapsing polychondritis (RP) is an inflammatory disorder that affects cartilage of ears, nose, joints, and respiratory tract. The inflammation often spreads to eyes, cardiovascular…
  • Abstract Number: 1106 • ACR Convergence 2020

    MMP Mediated Type I Collagen Degradation Is Associated with Erosive Hand Osteoarthritis in a Hospital-based Observational Cohort – the NOR-HAND Study

    Christian Thudium1, Neha Sharma2, Marthe Gløersen3, Peder Frederiksen2, Anne C. Bay-Jensen1 and Ida Haugen3, 1Nordic Bioscience, Herlev, Denmark, 2Nordic Bioscience, Herlev, 3Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Hand osteoarthritis (OA) is a common degenerative joint disease affecting mainly the interphalangeal and first carpometacarpal joints. The disease manifests as inflammation and deterioration…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology